Loading...

425 posters, 1 videos, 9 audios, 8 topics, 53 sessions, 340 authors, 286 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

22nd Annual Pain Medicine Meeting 2023

November 10 - 11, 2023 | New Orleans Marriott | New Orleans, Louisiana, USA

22nd Annual Pain Medicine Meeting 2023 banner

4852

PREVALENCE OF FALSE NEGATIVE RESULTS FOR HYDROCODONE IN ORAL FLUID TOXICOLOGY COMPARED WITH URINE TOXICOLOGY

Part of Topic

Chronic Pain

Prevalence of False Negative Results for Hydrocodone in Oral Fluid Toxicology Compared with Urine Toxicology

Saarang Singh, MD, Aakash Shah, MD, Evan Chung, MD, Joseph Valenza, MD


Introduction

  • This study aimed to compare the efficacy and reliability between oral fluid and urine studies in hydrocodone drug monitoring programs.  

Methods

  • 14 patients taking hydrocodone randomly selected from a Chronic Pain Center. PMP reports were reviewed prior.
  • Oral fluid and urine sample results from April to October 2021 were analyzed for each patient. 
  • Hydrocodone levels were measured using enzyme-linked immunoassay (ELISA) and liquid chromatography–mass spectrometry (LC/MS).
  • Test results were compared to each other to determine sensitivities of each test type.

Methods

  • Oral fluid studies had lower sensitivities with ELISA (71.4%) and LC/MS (85.7%) when compared to urine toxicology studies (100% for both)
  • Higher rates of false negative results were seen with oral fluid studies
  • LC/MS had fewer false negative results compared to ELISA
Discussion
  1. Oral fluid toxicology may result in more false negative results when compared to urine studies.
  2. LC/MS could be a more reliable modality in oral fluid testing when compared with ELISA.

 


22nd Annual Pain Medicine Meeting 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.